Guillain-Barr syndrome (GBS) is a rare neurological disorder characterized by the body's immune system mistakenly attacking the peripheral nerves
This finding contradicts the common practice among athletes of injecting directly into or around damaged ligaments
The drugs may also help reduce systemic inflammation, which is when the bodys immune system goes into overdrive trying to protect it from false threats
To view or add a comment, sign in What You Need to Know About the Pharma Sector in Iraq Iraqs pharmaceutical industry is shaped by strict rules and two key players: the Ministry of Health and KIMADIA, the state company that manages public imports of medicines
Even when discounts are available, coverage is increasingly restricted by: Strict prior authorization requirements Step-therapy mandates Employer plan exclusions State Medicaid budget limitations Data also shows that many patients regain weight after stopping GLP-1 medications, reinforcing concerns that these drugs may function more as a long-term maintenance therapy rather than a finite treatment
Or call us at 561-363-5538 to speak with our team